Markets
BSE See NSE See 37,363.43
809.83 (2.22%)
Laurus Labs Limited : In A Healthy Space

Laurus Labs Limited : In A Healthy Space

Print

India is considered to be one of the largest providers of quality, affordable generic drugs globally and Laurus Labs occupies a position of prime significance in this segment  

To read the entire article, you must be a DSIJ magazine subscriber.

 
 

 

Comments are only visible to subscribers.

DSIJ Mindshare

Sensex, Nifty rebound; Vodafone Idea zooms 14 per cent, Adani Green locks in at upper circuit

Geyatee Deshpande / Article rating: 4.3

On Friday, the bears lost their week-long grip on the domestic markets, as the benchmark indices such as Sensex and Nifty rebounded to climb up high, closing in the green. Sensex soared by 835.06 points or 2.28 per cent to settle at 37,388.66 levels while Nifty zoomed by 244.70 points or 2.26 per cent to close at 11,050.25 level.

Granules India hits record high; zooms 92 per cent in 3 months

Ganesh V / Article rating: 4.5

Granules India Limited today announced that United States Food & Drug Administration (USFDA) has approved its abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), which is a generic equivalent of Aleve PM Tablets, 220 mg/25 mg, of Bayer HealthCare LLC.

Vakrangee locks in at upper circuit; stock gains by more than 40 per cent from COVID-19 lows

Geyatee Deshpande / Article rating: 3.9

On Friday, the shares of Vakrangee Limited locked in at its upper circuit of 10 per cent at Rs 27.10 per share. The jump in the stock price was due to the company’s announcement about being granted an in-principle authorisation to set-up and operate the Bharat Bill Payment Operating Unit (BBPOU) by Reserve Bank of India (RBI).

12345Last